Related Experiment Videos
Using molecular epidemiology in assessing exposure for risk assessment
1National Institute for Occupational Safety and Health (NIOSH), Education and Information Division, Robert A. Taft Laboratories, Cincinnati, Ohio 45226, USA. pas4@cdc/gov
Annals of the New York Academy of Sciences
|February 17, 2000
Summary
Accurate health risk assessment requires understanding exposure, dose-response, and toxicity. Uncertainties often stem from limited exposure data and incomplete knowledge of exposure-disease pathways, especially with multiple exposures.
Area of Science:
- Environmental Health
- Toxicology
- Epidemiology
Background:
- Quantitative health risk assessment relies on exposure characterization, dose-response relationships, and agent toxicity.
- Significant uncertainties in risk assessment typically originate from inadequate exposure data and a poor understanding of exposure mechanisms and pathways.
- Variability in individual exposures and responses, alongside mixed or multiple exposures, further complicates risk assessment.
Purpose of the Study:
- To examine the critical role of exposure assessment in the overall risk assessment process.
- To explore the utility of biological markers and molecular epidemiology in enhancing exposure assessment for risk evaluation.
- To identify and discuss uncertainties associated with employing biological markers in risk assessment.
Main Methods:
- Review of existing literature on exposure assessment methodologies in health risk analysis.
- Analysis of the application and limitations of biological markers (biomarkers) in exposure assessment.
- Discussion of molecular epidemiology techniques for improving exposure data and understanding exposure-dose-response relationships.
Main Results:
- Exposure assessment is a primary driver of uncertainty in quantitative health risk estimation.
- Biological markers offer potential improvements in exposure assessment but introduce their own set of uncertainties.
- Understanding complex exposure pathways and individual variability is crucial for accurate risk characterization.
Conclusions:
- Improving exposure assessment is key to reducing uncertainty in health risk assessment.
- Biological markers and molecular epidemiology are valuable tools, but their application requires careful consideration of associated uncertainties.
- Further research is needed to refine exposure assessment techniques and biomarker utilization for more robust risk evaluations.